- Home
- APLT vs RAYA Comparison
APLT vs RAYA Comparison
Compare APLT & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | RAYA |
|---|---|---|
| Founded | 2016 | 2019 |
| Country | United States | China |
| Employees | N/A | 360 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 4.2M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | APLT | RAYA |
|---|---|---|
| Price | $0.12 | $4.06 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | ★ 27.2M | 32.1K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,000,000.00 | ★ $27,101,325.00 |
| Revenue This Year | $124.18 | $20.95 |
| Revenue Next Year | $66.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.11 | $3.13 |
| 52 Week High | $1.50 | $736.99 |
Technical Indicators
Market Signals| Indicator | APLT | RAYA |
|---|---|---|
| Relative Strength Index (RSI) | 25.40 | 55.31 |
| Support Level | $0.21 | $3.70 |
| Resistance Level | $0.26 | $5.62 |
| Average True Range (ATR) | 0.02 | 0.50 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 5.13 | 56.96 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.